Literature DB >> 23651405

Synergistic promotion of blood vessel regeneration by astragaloside IV and ferulic acid from electrospun fibrous mats.

Huan Wang1, Yun Zhang, Tian Xia, Wei Wei, Fang Chen, Xueqin Guo, Xiaohong Li.   

Abstract

The promotion of blood vessel initiation and growth plays an important role in the realization of therapeutic vascularization and regeneration of functional tissues. Astragalus membranaceus and angelica sinensis are commonly used traditional Chinese medicines for enriching the blood. In the current study astragaloside IV (AT, the main active ingredient of astragalus) and ferulic acid (FA, the main ingredient of angelica) were loaded into electrospun fibrous scaffolds to provide abundant and sustained biological factors required to initiate vascularization and bring it to maturity. The cell viability after AT and FA treatment was dose-dependent with an optimal concentration of around 50 μg/mL, and the most significant synergistic effect was demonstrated for the combined treatment with AT and FA with the ratio of 7/3 on both primary endothelial and smooth muscle cells. The in vitro release study showed that the amount of AT and FA release could be regulated by their loading amount and ratios in electrospun fibers. The localized and sustained codelivery of AT and FA indicated significantly high cell viability and secretion of extracellular matrices for both endothelial and smooth muscle cells, and induced significantly high densities of vascular structures after subcutaneous implantation. The most significant angiogenesis promotion with few inflammatory reactions was demonstrated for electrospun fibers containing AT and FA with the ratio of 7/3. It was suggested that the integration of the synergistic effect of Chinese medicine into electrospun fibrous scaffolds should provide clinical relevance for therapeutic vascularization, full vascularization in engineered tissues, and regeneration of blood vessel substitutes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23651405     DOI: 10.1021/mp400031y

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  4 in total

1.  Inhibitory Effects of Astragaloside IV on Bleomycin-Induced Pulmonary Fibrosis in Rats Via Attenuation of Oxidative Stress and Inflammation.

Authors:  Wei-Na Yu; Li-Feng Sun; Hua Yang
Journal:  Inflammation       Date:  2016-10       Impact factor: 4.092

2.  The effects of ferulic acid on the pharmacokinetics of warfarin in rats after biliary drainage.

Authors:  Haigang Li; Yang Wang; Rong Fan; Huiying Lv; Hua Sun; Haitang Xie; Tao Tang; Jiekun Luo; Zian Xia
Journal:  Drug Des Devel Ther       Date:  2016-07-06       Impact factor: 4.162

3.  Beneficial effects of astragaloside IV against angiotensin II-induced mitochondrial dysfunction in rat vascular smooth muscle cells.

Authors:  Yao Lu; Su Li; Hengfang Wu; Zhiping Bian; Jindan Xu; Chunrong Gu; Xiangjian Chen; Di Yang
Journal:  Int J Mol Med       Date:  2015-09-15       Impact factor: 4.101

Review 4.  Astragaloside IV: An Effective Drug for the Treatment of Cardiovascular Diseases.

Authors:  Heng-Wen Chen; Jun Li; Yu-Qing Tan
Journal:  Drug Des Devel Ther       Date:  2020-09-15       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.